D. Ekse

发表

Influence of plasma estrogen levels on the length of the disease-free interval in postmenopausal women with breast cancer

P. Lønning, H. Adlercreutz, S. Helle, 2005, Breast Cancer Research and Treatment.

An optimised, highly sensitive radioimmunoassay for the simultaneous measurement of estrone, estradiol and estrone sulfate in the ultra-low range in human plasma samples

P. Lønning, J. Geisler, Hildegunn Helle, 2008, The Journal of Steroid Biochemistry and Molecular Biology.

Total body aromatization in postmenopausal breast cancer patients is strongly correlated to plasma leptin levels

P. Lønning, M. Dowsett, J. Geisler, 2007, The Journal of Steroid Biochemistry and Molecular Biology.

Tissue estradiol is selectively elevated in receptor positive breast cancers while tumour estrone is reduced independent of receptor status

T. Aas, P. Lønning, J. Geisler, 2009, The Journal of Steroid Biochemistry and Molecular Biology.

Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer

S. Lundgren, V. Steen, J. Geisler, 2010, BMC Cancer.

The IGF-system in healthy pre- and postmenopausal women: relations to demographic variables and sex-steroids

P. Lønning, J. Holly, S. Helle, 2002, Journal of Steroid Biochemistry and Molecular Biology.

Plasma oestrogen fractions in postmenopausal women receiving hormone replacement therapy: influence of route of administration and cigarette smoking.

P. Lønning, J. Geisler, S. Helle, 1999, The Journal of endocrinology.

Letrozole is Superior to Anastrozole in Suppressing Breast Cancer Tissue and Plasma Estrogen Levels

T. Aas, P. Lønning, J. Geisler, 2008, Clinical Cancer Research.

Plasma estrogen suppression with aromatase inhibitors evaluated by a novel, sensitive assay for estrone sulphate

P. Lønning, J. Geisler, D. Johannessen, 1997, The Journal of Steroid Biochemistry and Molecular Biology.

Influence of aminoglutethimide on plasma levels of estrone sulphate and dehydroepiandrosterone sulphate in postmenopausal breast cancer patients

P. Lønning, J. Geisler, E. Lien, 1997, The Journal of Steroid Biochemistry and Molecular Biology.

A sensitive assay for measurement of plasma estrone sulphate in patients on treatment with aromatase inhibitors

P. Lønning, D. Ekse, 1995, The Journal of Steroid Biochemistry and Molecular Biology.

Effects of aminoglutethimide on plasma estrone sulfate not caused by aromatase inhibition.

P. Lønning, T. Thorsen, D. Johannessen, 1989, Journal of steroid biochemistry.

Influence of aminoglutethimide on plasma oestrogen levels in breast cancer patients on 4-hydroxyandrostenedione treatment

P. Lønning, T. Powles, M. Dowsett, 2005, Breast Cancer Research and Treatment.

The insulin-like growth factor system in human immunodeficiency virus infection: relations to immunological parameters, disease progression, and antiretroviral therapy.

P. Lønning, S. Frøland, T. Ueland, 2001, The Journal of clinical endocrinology and metabolism.

Treatment with high-dose estrogen (diethylstilbestrol) significantly decreases plasma estrogen and androgen levels but does not influence in vivo aromatization in postmenopausal breast cancer patients

P. Lønning, M. Dowsett, J. Geisler, 2005, The Journal of Steroid Biochemistry and Molecular Biology.

Breast cancer aromatase expression evaluated by the novel antibody 677: Correlations to intra-tumor estrogen levels and hormone receptor status

T. Aas, P. Lønning, J. Geisler, 2010, The Journal of Steroid Biochemistry and Molecular Biology.

Influence of droloxifene (3-hydroxytamoxifen), 40 mg daily, on plasma gonadotrophins, sex hormone binding globulin and estrogen levels in postmenopausal breast cancer patients

P. Lønning, J. Geisler, D. Ekse, 1995, The Journal of Steroid Biochemistry and Molecular Biology.

Effects of treatment with megestrol acetate on the insulin-like growth factor system: time and dose dependency.

S. Geisler, P. Lønning, S. Lundgren, 1999, European journal of cancer.

Relations between sex hormones, sex hormone binding globulin, insulin‐like growth factor‐I and insulin‐like growth factor binding protein‐I in post‐menopausal breast cancer patients

P. Lønning, H. Adlercreutz, G. Anker, 1995, Clinical endocrinology.

Influence of tamoxifen on sex hormones, gonadotrophins and sex hormone binding globulin in postmenopausal breast cancer patients

P. Lønning, H. Adlercreutz, T. Fotsis, 1995, The Journal of Steroid Biochemistry and Molecular Biology.

Influence of treatment with onapristone on the IGF-system in breast cancer patients

P. Lønning, W. Jonat, J. Holly, 1998, The Journal of Steroid Biochemistry and Molecular Biology.

Influence of treatment with aminoglutethimide on plasma and red-blood-cell glutathione status in breast cancer patients

P. Lønning, A. Svardal, R. Berge, 1998, Cancer Chemotherapy and Pharmacology.

Aminoglutethimide as an inducer of microsomal enzymes. Part 2: Endocrine aspects.

T. Thorsen, P. Lønning, D. Ekse, 1986, Breast cancer research and treatment.

Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer

S. Lundgren, V. Steen, J. Geisler, 2010, BMC Cancer.